Chronic lymphocytic leukemia in African Americans

Leukemia and Lymphoma

Volumn 53, Issue 11, 2012, Pages 2326-2329

  Coombs, Catherine C ^a   Falchi, Lorenzo ^b   Weinberg, J Brice ^a,c   Ferrajoli, Alessandra ^b   Lanasa, Mark C ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

African Americans; Chronic lymphocytic leukemia; ethnicity; health care disparities; outcomes; race

Indexed keywords

ADULT; AFRICAN AMERICAN; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER INCIDENCE; CANCER SURVIVAL; CAUCASIAN; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; ETHNICITY; GENE FREQUENCY; HEALTH CARE DISPARITY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES;

AFRICAN AMERICANS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEER PROGRAM;

EID: 84867154825     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.698276     Document Type: Conference Paper

References (33)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-15.
2. Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet 2008;371:1017-1029. (Pubitemid 351389535)
3. Lanasa MC. Novel insightsinto the biologyofCLL.Hematology Am Soc Hematol Educ Program 2010 :70-76.
4. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute. Based on November 2009 SEER data submission, posted to the SEER web site, 2010. Available from: http://seer.cancer.gov/csr/1975-2007/
5. Shenoy PJ, Malik N, Sinha R, et al. Racial dif erences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk 2011;11:498-506.
6. Olin LC, Schechter GP, Amdur R, et al. Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in African-Americans (AA), compared to Caucasians (Cauc): a retrospective analysis. J Clin Oncol 2008;26(May 20 Suppl.): Abstract 17558.
7. Chen L, Zhang Y, Zheng W, et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008;32:1491-1498.
8. Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, et al. Immuno-phenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Iran J Immunol 2008;5:25-35. (Pubitemid 351358026)
9. Tomomatsu J, Isobe Y, Oshimi K, et al. Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic prof le, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior. Leuk Lymphoma 2010; 51 :2230-2239.
10. Gunawardana C, Austen B, Powell JE, et al. South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients. Br J Haematol 2008; 142 :606-609. (Pubitemid 352020209)
11. Mukiibi JM, Paul B, Nyirenda CM, et al. Chronic lymphocytic leukaemia (CLL) in Central Africans. Cent Afr J Med 2004;50:111-115.
12. Shamebo M, Gebremedhin A. Chronic lymphocytic leukaemia in Ethiopians. East Afr Med J 1996;73:643-646.
13. Omoti CE, Awodu OA, Bazuaye GN. Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria. Int J Lab Hematol 2007;29:426-432. (Pubitemid 350060625)
14. Salawu L, Bolarinwa RA, Durosinmi MA. Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, SouthWestern Nigeria. Afr Health Sci 2010;10:187-192.
15. Amundadottir LT, Torvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
16. Goldin LR, Pfeifer RM, Li X, et al. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 2004;104:1850-1854. (Pubitemid 39202296)
17. Kerber RA, O'Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 2005;103:1906-1915. (Pubitemid 40563264)
18. Sellick GS, Goldin LR, Wild RW, et al. A high-density SNP genome-wide linkage search of 206 families identif es susceptibility loci for chronic lymphocytic leukemia. Blood 2007; 110 :3326-3333. (Pubitemid 350106326)
19. Fuller SJ, Papaemmanuil E, McKinnon L, et al. Analysis of a large multi-generational family provides insight into the genetics of chronic lymphocytic leukemia. Br J Haematol 2008; 142 :238-245. (Pubitemid 351987326)
20. Sherborne AL, Houlston RS. What are genome-wide association studies telling us about B-cell tumor development? Oncotarget 2010;1:367-372.
21. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identif es six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008; 40 :1204-1210.
22. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 inf uence chronic lymphocytic leukemia risk. Nat Genet 2010;42:132-136.
23. Crowther-Swanepoel D, Corre T, Lloyd A, et al. Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. Blood 2010;116:5957-5960.
24. Slager SL, Goldin LR, Strom SS, et al. Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2010;19:1098-1102.
25. Slager SL, Rabe KG, Achenbach SJ, et al. Genome-wide association study identif es a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2011;117:1911-1916.
26. Crowther-Swanepoel D, Broderick P, Ma Y, et al. Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum Mol Genet 2010;19:1840-1845.
27. Lan Q, Au WY, Chanock S, et al. Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong. Eur J Haematol 2010;85:492-495.
28. Ghafoor A, Jemal A, Cokkinides V, et al. Cancer Statistics for African Americans. CA Cancer J Clin 2002; 52 :23-47.
29. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
30. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-2726. (Pubitemid 38725421)
31. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:78-93. (Pubitemid 38519418)
32. Davies SM. Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet? Hematology Am Soc Hematol Educ Program, 2006 :111-117.
33. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA 2002; 287 :2106-2113. (Pubitemid 34437345)